Peer review Peer review information Nature Communications thanks Rudolf Oehler, Robert Hoffman and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
By activating these receptors, GLP-1 therapy can naturally decrease appetite, helping you feel satisfied with smaller portions and supporting long-term weight loss efforts
The MHRA approved it on 11 June 2026
Vagaries of conditional gene targeting
Patients should seek urgent medical attention if they experience severe, persistent abdominal pain (which may indicate pancreatitis) or symptoms of gallbladder disease (right upper abdominal pain, fever, jaundice)
Diarrhea lasted a median of 3 days